-
"One of the nation's premier plaintiffs' firms."
American Lawyer
-
"Representing the best qualities of the plaintiffs' bar."
The National Law Journal
-
"Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."
The Daily Journal
Media Center
Fosamax and Other Osteoporosis Drugs: New Study on Risk of Thigh Bone Fractures
May 6, 2011
In a study published on May 4, 2011 in the New England Journal of Medicine, researchers found osteoporosis drugs known as bisphosphonates, such as Actonel, Boniva, and Fosamax, show a statistically significant, several-fold increased risk of atypical femur fracture for less than a year of use, and a particularly high (50x) risk after 1.9 years of use.
In an earlier study published in February 2011 in the Journal of the American Medical Association, long-term use of bisphosphonates was also associated with an increased risk of rare femur fractures.
Lieff Cabraser represents patients injured by prescription drugs with dangerous undisclosed side effects. Learn more about osteoporosis bone drug lawsuits.